9. Bibliografia

  1. Blumberg S., Biefang D.,Kantrowitz F.G.: A possible association between influenza vaccination and small vessel vasculitis Arch. Intern. Med. 140: 847, 1980
  2. Deodati F. :Optic neuritis due to ethambutol. Rev. Otoneuro-ophthalmol.46:191,1974
  3. Donaldson R.C., Canaan S.A.J., McLean R.B., Ackerman L.V.: Uveitis and vitiligo associated with BCG tratment for malignant melanoma . Surgery 76:771,1974
  4. Dorigo M.T., Altafini R., Cecchinato A.: Danni oculari da farmaci topici e sistemici. Ed. Cleup Padova 1989
  5. Dorigo M.T.,Moro F.: Malattie oculari da farmaci di impiego topico e sistemico. P.637. In Patologia Medica , Piccin editore. Padova 1989
  6. Dorigo M.T., Altafini R.: Aging and drug-induced optic nerve side effects. Met.Ped.Syst. and Ophthalmol.12:24,1989
  7. Dorigo M.T. e Moro F.: Effetti oculari avversi da farmaci sistemici. p .195 in Farmacologia oculare. Atti del III Congresso di Farmacologia Oculare . Venezia 1992. III vol. Cappelli ed. Bologna 1992
  8. Fraunfelder F.T.: Drug induced ocular side effects and drug interaction. Ed. Lea & Febiger. Philadelphia, 1982
  9. Fraunfelder F.T.,Hanna C.,Dreis M.V., Cosgrove K.W. Jr.: Cataract associated with allopurinol therapy. Am.J.Ophthalmol.: 94:137,1982
  10. Fuller J.D., Stanfield L.E.D., Craven D.E: Rifabutin prophylaxis and uveitis (letter). N. Engl.J. Med. 330:1315,1994
  11. Godel V., Nemet P.,Lazar M.: Chloramphenicol optic neuropathy. Arch. Ophthalmol 98: 1419,1980
  12. Grosset J.,Leventis S.: Adverse effects of rifampin. Rev. Infect. Dis.5 (Suppl.) :440,1983
  13. Havlir D., Torriana F., Dube M.: Uveitis associated with rifabutin prophylaxis. Ann.Intern. Med.1212: 510, 1994
  14. Hockwin J.: Drug induced ocular side effects and ocular toxicology. Ed.Karger, Basel 1987
  15. Jones B.R., Anderson J., Fuglsang H.: Effects of various concentrations of diethylcarbamazine citrate applied as eye drop in ocular onchocerchiasis, and the possibilities of improved therapy from continuous non-pulsed delivery. Br.J.Ophthalmol. 62:428,1978
  16. Karbassi M., Nikou S.: Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin. Arch.Ophthalmol. 113:699,1995
  17. Karmon G. :Bilateral optic neuropathy due to combined ethambutol and isoniazide treatment. Ann. Ophthalmol. 11:1013,1979
  18. Kass I. : Isoniazide as a cause of optic neuritis and atrophy. JAMA 164:1740 1957
  19. Keeping J.A. and Davidson S.I.: Reported adverse effects of oral contraceptives on the eye. Trans. Ophthalmol. Soc. U.K. 91:561,1971
  20. Knopf H.L.S.: Recurrent uveitis after influenza vaccination. Ann. Ophthalmol. 23:213,1991
  21. Krauss G.L.,Johnson M.A and Miller N.R.:Vigabatrin-associated retinal cone system dysfunction: Electroretinogram and ophthalmologic findings Neurology 50 (3):614,1998
  22. Lafond G., Roi P.E., Greiner R.,: Lens opacities appearing during therapy with methoxsalen and long-wavelenght ultraviolet radiation. Can. J.Ophthalmol. 19:173,1984
  23. Lakhanpal C.,Schocket S.S.: Deferoxamine (Desferal) induced toxic retinal pigmentary degenaration and presumed optic neuropathy . Ophthalmology 91:443,1984
  24. Lerman S., Megaw J.M., Fraunfelder F.T. : Further studies on allopurinol therapy and human cataractogenesis. Am.J. Ophthalmol. 97:205,1984
  25. Lish A., Berman D.H.: Tubercolin-triggered panuveitis in a patient recently treated for active pulmonary tubercolosis Am. J.Ophthalmol.116:771,1993
  26. Moorthy R.S., Valluri S. and Jampol L.M.: Drug-induced uveitis. Therapeutic review. Surv. Ophthalmol. 42:557,1998
  27. Nussemblatt R.B., Palestine A.G.: Uveitis Fundamentals and Practice. Chicago, Yearbook Medical publisher,1989, p288
  28. Ophthalmic Drug Facts 99. P.307-313. Ed.Facts and Comparison. St. Louis 1999
  29. Price G.E.: Artritis and iritis after BCG therapy for bladder cancer. J.Rheumatol 21:564,1994
  30. Radnot M., Follman P.:Ocular side-effects of oral contraceptives. Ann.Clin. Res. 5:197,1973
  31. Sanderson P.A. Kuwabara T., Cogan D.G.: Optic neuropathy presumably caused by vincristine therapy. Am.J.Ophthalmol. :81:146,1976
  32. Saran B.R., Maguire A.M., Nichols C.,et al.: Hypopion uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch. Ophthalmol. 112:1159,1994
  33. Searle C.W.A: Optic neuritis following isoniazid therapy. Lancet 2:278, 1955
  34. Stern R.S.,Parrish J.A., Fitzpatrick T.B.: Ocular findings in patients treated with PUVA. J.Invest. Dermatol. 85:269,1985
  35. Tilden M.E., Rosenbaum J.T., Fraunfelder F.T.: Systemic sulfonoamides as a cause of bilateral, anterior uveitis. Arch. Ophthalmol.:109: 67,1991
  36. Vanthalao S., Paakkonen L.: Visual field constriction in children treated with vigabatrin. Neurology, 52:1713,1998
  37. Walsh F.B., Clark D.B., Thompson R.S., et al.: Oral contraceptives and neuro-ophthalmic interest. Arch.Ophthalmol. 74:628,1965
  38. Walker G.F. : Blindness during streptomycin and chloramphenicol therapy. Br.J.Ophthalmol.45:555,1961
  39. Wilson E.A., Brodie M.J.: Severe persistent visual field constriction associated with vigabatrin.B.M.J. 314:1693, 1997
Precedente
Indice